Advanced

R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.

Holte, Harald; Leppa, Sirpa M.; Bjorkholm, Magnus; Fluge, Oystein; Jyrkkio, Sirkku; Delabie, Jan; Sundstrom, Christer; Karjalainen-Lindsberg, Marja-Liisa; Erlanson, Martin and Kolstad, Arne, et al. (2008) 50th Annual Meeting of the American- Society-of-Hematology In Blood 112(11). p.1233-1233
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
112
issue
11
pages
1233 - 1233
publisher
American Society of Hematology
conference name
50th Annual Meeting of the American- Society-of-Hematology
external identifiers
  • wos:000262104704222
ISSN
1528-0020
language
English
LU publication?
yes
id
78078f2b-94a4-430e-aca1-659b9a4dc394 (old id 1375521)
date added to LUP
2009-04-29 14:22:22
date last changed
2016-04-15 20:29:22
@misc{78078f2b-94a4-430e-aca1-659b9a4dc394,
  author       = {Holte, Harald and Leppa, Sirpa M. and Bjorkholm, Magnus and Fluge, Oystein and Jyrkkio, Sirkku and Delabie, Jan and Sundstrom, Christer and Karjalainen-Lindsberg, Marja-Liisa and Erlanson, Martin and Kolstad, Arne and Fossa, Alexander and Ostenstad, Bjorn and Lofvenberg, Eva and Nordstroem, Marie and Moller-Pedersen, Lars and Anderson, Harald and Jerkeman, Mats and Eriksson, Mikael},
  issn         = {1528-0020},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {11},
  pages        = {1233--1233},
  publisher    = {American Society of Hematology},
  series       = {Blood},
  title        = {R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.},
  volume       = {112},
  year         = {2008},
}